RSS | Print | PDF | Email Page

Appellate Standing Not Precluded By Inability To Maintain Hatch-Waxman Suit, PTAB Litigation Blog

January 2019

Visit the PTAB Litigation Blog.

Mylan Pharmaceuticals, Inc. petitioned for inter partes review (IPR) of U.S. Patent No. 6,858,650 (the "'650 Patent"), which is owned by UCB Pharma GmbH ("UCB") and is directed to chemical derivatives of a drug for treating urinary incontinence

Read the full article at